• ȨÆäÀÌÁö
    ¿µ¾î
    Áß±¹¾î
    »çÀÌÆ®Áöµµ
    JOIN
  • Username (Site Login ID)
  • Password
  • Forgot your password?

  • Cases and Studies of Culture & Economy in Lottery & Gambling

    date : 2015-05-20 01:10|hit : 416
    Article] Cognitive-educational treatment of fibromyalgia: A randomized clinical trial .2. Economic evaluation
    DocNo of ILP: 7685

    Doc. Type: Article

    Title: Cognitive-educational treatment of fibromyalgia: A randomized clinical trial .2. Economic evaluation

    Authors: Goossens, MEJB; RuttenvanMolken, MPMH; Leidl, RM; Bos, SGPM; Vlaeyen, JWS; TeekenGruben, NJG

    Full Name of Authors: Goossens, MEJB; RuttenvanMolken, MPMH; Leidl, RM; Bos, SGPM; Vlaeyen, JWS; TeekenGruben, NJG

    Keywords by Author: fibromyalgia; costs; cognitive-behavioral treatment; economic evaluation; utilities; qaly

    Keywords Plus: RHEUMATOLOGY

    Abstract: Objective. In this 3 year randomized clinical trial the cost effectiveness of a 6 week educational/cognitive intervention (ECO) is compared with an educational discussion intervention (EDI) and a waiting list condition (WLC). Methods. A total of 131 patients with fibromyalgia were randomly allocated to the ECO, EDI, or WLC intervention. The ECO and EDI groups were followed for 12 months, whereas the WLC group was followed for 6 weeks. Direct health care and nonhealth care costs, and the indirect costs associated with lost production due to illness, were calculated. The effects were measured in terms of utilities, using rating scale and standard gamble methods. Results. Treatment costs were estimated to be US $980 per patient for both ECO and EDI. The total direct health care costs of ECO treatment were US $1623 higher than those for EDI. This difference was significant. Indirect costs for the 2 groups were not significantly different, At 6 weeks there was a significant difference in rating scale utilities between the 3 groups, caused by a significantly greater improvement in the EDI group compared to the WLC group. However, no significant differences in either rating scale or standard gamble utilities were found between the ECO and EDI groups immediately after treatment, or at the 6 or 12 month followups. Conclusion. The economic evaluation showed that the addition of a cognitive component to the educational intervention led to significantly higher health care costs and no additional improvement in quality of life compared to the educational intervention alone. This conclusion is robust through a range of plausible values used in a sensitivity analysis.

    Cate of OECD: Clinical medicine

    Year of Publication: 1996

    Business Area: other

    Detail Business: medicine & science

    Country: Canada

    Study Area: industry, production, Evaluation, clinical trial, clinical trial, patient, behavior

    Name of Journal: JOURNAL OF RHEUMATOLOGY

    Language: English

    Country of Authors: UNIV LIMBURG,DEPT PSYCHOL MED,6200 MD MAASTRICHT,NETHERLANDS; INST REHABIL RES,HOENSBROEK,NETHERLANDS

    Press Adress: Goossens, MEJB (reprint author), UNIV LIMBURG,DEPT HLTH ECON,6200 MD MAASTRICHT,NETHERLANDS.

    Email Address:

    Citaion:

    Funding:

    Lists of Citation: BAKKER C, 1994, J RHEUMATOL, V21, P1298; BAKKER C, 1994, J RHEUMATOL, V21, P269; BAKKER CH, 1993, PATIENT EDUC COUNS, V20, P145, DOI 10.1016/0738-3991(93)90128-J; BENNETT K, 1991, CONTROLLED CLIN TR S, V12, P118; BLEICHRODT H, 1993, 9323 ER U ROTT I MED; CATHEY BSN, 1986, AM J MED, V81; DEGIROLAMO G, 1991, CLIN J PAIN, V7, pS1; Drummond MF, 1987, METHODS EVALUATION H; HAWLEY DJ, 1988, J RHEUMATOL, V15, P1551; KOOPMANSCHAP MA, 1993, PHARMACOECONOMICS, V4, P446, DOI 10.2165/00019053-199304060-00006; LIGHTFOOT RW, 1993, ANN INTERN MED, V119, P503; MCCARTHY J, 1989, HORIZONS, V16, P174; MULLEY AG, 1989, MED CARE, V27, pS269, DOI 10.1097/00005650-198903001-00021; READ JL, 1984, MED DECIS MAKING, V4, P315, DOI 10.1177/0272989X8400400307; RUTTENVANMOLKEN MPMH, 1994, HEALTH ECON, V3, P333, DOI 10.1002/hec.4730030507; RUTTENVANMOLKEN MPMH, 1995, MED CARE, V33, P922; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Vlaeyen JWS, 1996, J RHEUMATOL, V23, P1237; WOLFE F, 1990, ARTHRITIS RHEUM, V33, P160, DOI 10.1002/art.1780330203; WOLFE F, 1990, RHEUM DIS CLIN N AM, V16, P681

    Number of Citaion: 20

    Publication: J RHEUMATOL PUBL CO

    City of Publication: TORONTO

    Address of Publication: 920 YONGE ST, SUITE 115, TORONTO ON M4W 3C7, CANADA

    ISSN: 0315-162X

    29-Character Source Abbreviation: J RHEUMATOL

    ISO Source Abbreviation: J. Rheumatol.

    Volume: 23

    Version: 7

    Start of File: 1246

    End of File: 1254

    DOI:

    Number of Pages: 9

    Web of Science Category: Rheumatology

    Subject Category: Rheumatology

    Document Delivery Number: UV681

    Unique Article Identifier: WOS:A1996UV68100022

    [ÀÌ °Ô½Ã¹°Àº HyeJung Mo¡¦´Ô¿¡ ÀÇÇØ 2015-05-20 17:19:44 GAMBLING¿¡¼­ À̵¿ µÊ]
    reply : 0
  • list
  • prev
  • next